ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
9.88
-1.03 (-9.40%)
Aug 14, 2026, 11:16 AM EDT - Market open
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $89.34 million as of August 14, 2026. Its market cap has increased by 51.38% in one year.
Market Cap
89.34M
Enterprise Value
95.30M
1-Year Change
51.38%
Ranking
Category
Stock Price
$9.88
ChartMarket Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $89.34M, an increase of 4,384.80%. That is a compound annual growth rate of 11.72%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 89.34M | 60.59% |
| Dec 31, 2025 | 55.63M | 21.22% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fractyl Health | 107.44M |
| Tenax Therapeutics | 104.83M |
| Pelthos Therapeutics | 103.57M |
| Inovio Pharmaceuticals | 100.60M |
| Fortress Biotech | 98.99M |
| Cognition Therapeutics | 98.42M |
| PolyPid | 97.90M |
| Oncolytics Biotech | 96.20M |